Detalhe da pesquisa
1.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
J Eur Acad Dermatol Venereol
; 37(10): 1991-1998, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335879
2.
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(9)2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922388
3.
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models.
Int J Mol Sci
; 22(6)2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802212
4.
Osimertinib.
Recent Results Cancer Res
; 211: 257-276, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30069773
5.
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Oncol Ther
; 12(1): 163-171, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37973688
6.
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
J Chemother
; 35(6): 576-582, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537289
7.
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
Oncol Ther
; 10(1): 291-300, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066813
8.
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Transl Oncol
; 23: 101471, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779323
9.
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy.
Genes (Basel)
; 12(7)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209514
10.
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Genes (Basel)
; 12(2)2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33671892
11.
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.
Genes (Basel)
; 12(9)2021 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34573384
12.
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
Genes (Basel)
; 12(5)2021 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946594
13.
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature.
Oncol Ther
; 8(2): 333-339, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700042
14.
Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review.
Oncol Ther
; 8(2): 341-350, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700047
15.
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.
Diagnostics (Basel)
; 10(12)2020 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297595
16.
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs.
J Clin Med
; 9(4)2020 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272775
17.
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence.
Pharmacol Ther
; 196: 105-116, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30521884
18.
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.
Clin Lung Cancer
; 20(3): 178-185.e2, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910574
19.
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.
J Cancer Res Clin Oncol
; 145(2): 479-485, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506406
20.
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Oncol Ther
; 12(1): 173-174, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170387